Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Metrics to compare | MEDI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDIPeersSector | |
---|---|---|---|---|
P/E Ratio | 32.4x | 22.4x | −0.5x | |
PEG Ratio | 1.63 | 0.05 | 0.00 | |
Price/Book | 8.5x | 3.5x | 2.6x | |
Price / LTM Sales | 6.6x | 3.8x | 3.3x | |
Upside (Analyst Target) | 6.0% | 19.6% | 42.9% | |
Fair Value Upside | Unlock | 9.0% | 6.2% | Unlock |